Holly J. Meany

Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multi-Tumor Associated Antigen Specific Cytotoxic T Lymphocytes: A Phase I Study

Amy B Hont, Carolina Colli Cruz, Robert Ulrey et al. · Journal of Clinical Oncology · 2019 · 74 citations · Full text

18‐fluorodeoxyglucose‐positron emission tomography (FDG‐PET) evaluation of nodular lesions in patients with neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST)

Holly J. Meany, Eva Dombi, James C. Reynolds et al. · Pediatric Blood & Cancer · 2012 · 67 citations

Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children’s Oncology Group Study ANBL0531

Clare J. Twist, Arlene Naranjo, Mary Lou Schmidt et al. · Journal of Clinical Oncology · 2018 · 61 citations

Utility of PET scans to predict disease relapse in pediatric patients with Hodgkin lymphoma

Holly J. Meany, Vinod K. Gidvani, Caterina P. Minniti · Pediatric Blood & Cancer · 2006 · 55 citations

Significance of clinical and biologic features in Stage 3 neuroblastoma: A report from the International Neuroblastoma Risk Group project

Holly J. Meany, Wendy B. London, Peter F. Ambros et al. · Pediatric Blood & Cancer · 2014 · 42 citations